Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01
Published September 4, 2024 · Recall initiated: August 21, 2024
Summary
FDA records drug Class II recall D-0648-2024, published September 4, 2024 and initiated August 21, 2024. Recalling firm: Lupin Pharmaceuticals Inc.; Status: Terminated; Reported quantity: 4554 bottles; Lot: Lot #: F201517, Exp 11/30/2024. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
What to do
Voluntary: Firm initiated · Letter
Get an email if CEFIXIME has another recall
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Brand
- CEFIXIME
- Manufacturer
- Lupin Pharmaceuticals Inc.
- Distributor
- USA nationwide.
- UPC
- 0368180423089
- Lot
- Lot #: F201517, Exp 11/30/2024
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAIbuprofen Tablets, USP 400mg, Generic for Motrin, Pkg Size: 30 tablets per bottle, Mfg: Dr. Reddy'sSeptember 4, 2024
- FDASpice Class brand Ground Cinnamon packed in 7oz and 11oz PET jarsSeptember 4, 2024
- FDACefixime for Oral Suspension USP 200 mg/5 mL (50 mL Pack size), Powder for oral suspension, Rx only,June 26, 2024
- FDACefixime for Oral Suspension 100mg/5mL, 50 mL bottle, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc.,February 7, 2024
- FDACefixime Capsules, 400 mg, 50-count bottles, Rx only, Manufactured by: Alkem Laboratories Ltd., Mumbai, India,January 12, 2022
- FDACefixime Capsules 400 mg, 50 capsules bottles, Rx Only, Manufactured by: Alken Laboratories Ltd., Mumbai - 400November 17, 2021
Questions about this recall
Was Cefixime for Oral Suspension USP, 100 mg/5 mL, 50 mL bottle, Rx only, Manufactured for: Lupin Pharmaceuticals, Inc., Baltimore, Maryland 21202, Manufactured by: Lupin Limited, Mandideep 462 046 INDIA, NDC 68180-405-01 recalled?
Yes. FDA published recall D-0648-2024 on September 4, 2024. Reported hazard: Subpotent Drug- An out of specification ( OOS ) result observed in assay test during 18-month long term stability study.
What should I do if I have this product?
Voluntary: Firm initiated · Letter
How do I know if my unit is part of the recall?
Compare your product details with the notice. Brand: CEFIXIME. UPC: 0368180423089.